Biocryst Pharmaceuticals (BCRX) EBITDA (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted EBITDA of $98.98 million for Q2 2026, up 228.7% from $30.12 million a year earlier.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) EBITDA (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Biocryst Pharmaceuticals was -$310.85 million; for FY2025, it came in at $342.38 million.
- In prior years, Biocryst Pharmaceuticals' EBITDA was -$1.3 million in FY2024, -$102.05 million in FY2023, -$147 million in FY2022 and -$176.94 million in FY2021.
- Quarterly EBITDA has run from a low of -$700.54 million in Q1 2026 to a high of $260.78 million in Q4 2025 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$700.54 million (Q1 2026), $260.78 million (Q4 2025) and $29.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 940.71 Mn | 214.41 Mn | 98.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.98 Mn |
| Mar 31, 2026 | -700.54 Mn |
| Dec 31, 2025 | 260.78 Mn |
| Sep 30, 2025 | 29.93 Mn |
| Jun 30, 2025 | 30.12 Mn |
| Mar 31, 2025 | 21.56 Mn |
| Dec 31, 2024 | -4.20 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | -14.18 Mn |
| Dec 31, 2023 | -42.25 Mn |
| Sep 30, 2023 | 10.85 Mn |
| Jun 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | -7.79 Mn |
| Dec 31, 2022 | -2.12 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | -16.67 Mn |
| Mar 31, 2022 | -30.64 Mn |
| Dec 31, 2021 | -34.24 Mn |
| Sep 30, 2021 | -30.58 Mn |
API Access
Biocryst Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();